Generics

Lupin intros authorized generic Duexis
Ibuprofen and famotidine tablets are indicated for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, the company said,
Alembic launches generic Anafranil
Alembic's generic Anafranil capsules provide a treatment for obsessions and compulsions in patients with OCD.

Sandoz enters agreement with Bio-Thera Solutions for Avastin biosimilar

Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that targets vascular endothelial growth factor, a key mediator of angiogenesis in cancer.
AAM makes 2 key appointments

The organization is welcoming Polly Webster as vice president of federal affairs and Erik Komendant as senior vice president of government affairs.
FDA approves 2 generics from VGYAAN Pharmaceuticals

The Food and Drug Administration has approved the company’s generics of Tegretol (carbamazapene tablets) and Lupron (leuprolide acetate injection).
Sandoz Canada debuts generic Revlimid

The company said Canada would be the fifth country in which it is commercializing the product.
FDA marks competitive generic therapy approval milestone

The agency has approved more than 100 generic drugs with the competitive generic therapy designation since it launched the effort in 2017.
FDA approves generic Metrogel Gel from Alembic’s Aleor Dermaceuticals

The product had an estimated $29 million U.S. market size for the year ended June 2021, according to data from IQVIA.
Dr. Reddy's intros generic Revlimid in Canada

Reddy-Lenalidomide capsules are available in six dosage strengths.
Hikma, Bio-Thera Solutions partner on potential Stelara biosimilar

Bio-Thera will maintain responsibility for development, manufacturing and supply of the biosimilar Stelara while Hikma will have exclusive rights to commercialize the product in the United States.

Lupin intros authorized generic Duexis

Alembic launches generic Anafranil

Sandoz enters agreement with Bio-Thera Solutions for Avastin biosimilar

AAM makes 2 key appointments

FDA approves 2 generics from VGYAAN Pharmaceuticals

Sandoz Canada debuts generic Revlimid

FDA marks competitive generic therapy approval milestone

FDA approves generic Metrogel Gel from Alembic’s Aleor Dermaceuticals

Dr. Reddy's intros generic Revlimid in Canada

Hikma, Bio-Thera Solutions partner on potential Stelara biosimilar